Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission.
Tasaki S, Suzuki K, Kassai Y, Takeshita M, Murota A, Kondo Y, Ando T, Nakayama Y, Okuzono Y, Takiguchi M, Kurisu R, Miyazaki T, Yoshimoto K, Yasuoka H, Yamaoka K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T. Tasaki S, et al. Among authors: okuzono y. Nat Commun. 2018 Jul 16;9(1):2755. doi: 10.1038/s41467-018-05044-4. Nat Commun. 2018. PMID: 30013029 Free PMC article.
Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sjögren's syndrome.
Tasaki S, Suzuki K, Nishikawa A, Kassai Y, Takiguchi M, Kurisu R, Okuzono Y, Miyazaki T, Takeshita M, Yoshimoto K, Yasuoka H, Yamaoka K, Ikeura K, Tsunoda K, Morita R, Yoshimura A, Toyoshiba H, Takeuchi T. Tasaki S, et al. Among authors: okuzono y. Ann Rheum Dis. 2017 Aug;76(8):1458-1466. doi: 10.1136/annrheumdis-2016-210788. Epub 2017 May 18. Ann Rheum Dis. 2017. PMID: 28522454 Free PMC article.
Gene Signature-Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease.
Gamo K, Okuzono Y, Yabuki M, Ochi T, Sugimura K, Sato Y, Sagara M, Hayashi H, Ishimura Y, Nishimoto Y, Murakawa Y, Shiokawa Z, Gotoh M, Miyazaki T, Ebisuno Y. Gamo K, et al. Among authors: okuzono y. Inflamm Bowel Dis. 2018 May 18;24(6):1251-1265. doi: 10.1093/ibd/izy079. Inflamm Bowel Dis. 2018. PMID: 29669006 Free PMC article.
Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell.
Takeshita M, Suzuki K, Kondo Y, Morita R, Okuzono Y, Koga K, Kassai Y, Gamo K, Takiguchi M, Kurisu R, Mototani H, Ebisuno Y, Yoshimura A, Takeuchi T. Takeshita M, et al. Among authors: okuzono y. Ann Rheum Dis. 2019 Oct;78(10):1346-1356. doi: 10.1136/annrheumdis-2018-214885. Epub 2019 Jun 5. Ann Rheum Dis. 2019. PMID: 31167762 Free PMC article.
Molecular remission at T cell level in patients with rheumatoid arthritis.
Inamo J, Suzuki K, Takeshita M, Kondo Y, Okuzono Y, Koga K, Kassai Y, Takiguchi M, Kurisu R, Yoshimura A, Takeuchi T. Inamo J, et al. Among authors: okuzono y. Sci Rep. 2021 Aug 17;11(1):16691. doi: 10.1038/s41598-021-96300-z. Sci Rep. 2021. PMID: 34404865 Free PMC article.
Reduced TREM2 activation in microglia of patients with Alzheimer's disease.
Okuzono Y, Sakuma H, Miyakawa S, Ifuku M, Lee J, Das D, Banerjee A, Zhao Y, Yamamoto K, Ando T, Sato S. Okuzono Y, et al. FEBS Open Bio. 2021 Nov;11(11):3063-3080. doi: 10.1002/2211-5463.13300. Epub 2021 Sep 28. FEBS Open Bio. 2021. PMID: 34523252 Free PMC article.
34 results